Researchers find possible cause for chemoresistance in bowel cancer

by Martin-Luther-Universität Halle-WittenbergAnalysis of IGF2BP2 targets in tumor and metastatic CRC tissues. A, B Cumulative plot of gene expression (log2 fold change) in primary (A) and metastatic (

Updated on: January 30,2024 20

Researchers find possible cause for chemoresistance in bowel cancer

by Martin-Luther-Universität Halle-WittenbergAnalysis of IGF2BP2 targets in tumor and metastatic CRC tissues. A, B Cumulative plot of gene expression (log2 fold change) in primary (A) and metastatic (

Updated on:January 30,2024 20

Researchers develop novel approach for predicting resistance against cancer therapy

by National University of SingaporeMultispectral microscopy with quantitative immunofluorescence is a state-of-the-art technology that can detect oncogenes simultaneously, allowing for the identi

Updated on: February 18,2024 14

Researchers develop novel approach for predicting resistance against cancer therapy

by National University of SingaporeMultispectral microscopy with quantitative immunofluorescence is a state-of-the-art technology that can detect oncogenes simultaneously, allowing for the identi

Updated on:February 18,2024 14

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on: January 23,2024 14

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on:January 23,2024 14

Stopping cancer from recruiting immune system double agents

by Rush University Medical CenterCredit: Rush University Medical CenterCancerous tumors trick myeloid cells, an important part of the immune system, into perceiving them as a damaged part of the

Updated on: April 01,2024 13

Stopping cancer from recruiting immune system double agents

by Rush University Medical CenterCredit: Rush University Medical CenterCancerous tumors trick myeloid cells, an important part of the immune system, into perceiving them as a damaged part of the

Updated on:April 01,2024 13

Blocking proteins could pull the plug on power for colon tumors

by Virginia Commonwealth UniversityCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113081Throughstudy findingspublished inCell Reports, a team of scientists at

Updated on: April 01,2024 14

Blocking proteins could pull the plug on power for colon tumors

by Virginia Commonwealth UniversityCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113081Throughstudy findingspublished inCell Reports, a team of scientists at

Updated on:April 01,2024 14

Enzyme inhibition promotes bone formation and curbs the development of bone metastases, study finds

byGerman Cancer Research CenterNegative regulation of bone formation by TAM receptor MERTK.amRNA expression analysis of TAM receptor familyMertk,Tyro3,Axl,Gas

Updated on: January 23,2024 19

Enzyme inhibition promotes bone formation and curbs the development of bone metastases, study finds

byGerman Cancer Research CenterNegative regulation of bone formation by TAM receptor MERTK.amRNA expression analysis of TAM receptor familyMertk,Tyro3,Axl,Gas

Updated on:January 23,2024 19

Diagnostic performance of contrast-enhanced ultrasound using perfluorobutane for high-risk hepatocellular carcinoma

byAmerican Roentgen Ray Society(A) Arterial-phase CEUS image (12 seconds after injection) shows 25-mm segment-8 lesion with nonrim hyperenhancement (arrow). (B) CEUS image in portal-venous phase

Updated on: January 02,2024 8

Diagnostic performance of contrast-enhanced ultrasound using perfluorobutane for high-risk hepatocellular carcinoma

byAmerican Roentgen Ray Society(A) Arterial-phase CEUS image (12 seconds after injection) shows 25-mm segment-8 lesion with nonrim hyperenhancement (arrow). (B) CEUS image in portal-venous phase

Updated on:January 02,2024 8

A new targeted treatment shows promise for select patients with stomach cancer

byWeill Cornell Medical CollegeCredit: Pixabay/CC0 Public DomainAn international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, has found tha

Updated on: January 29,2024 13

A new targeted treatment shows promise for select patients with stomach cancer

byWeill Cornell Medical CollegeCredit: Pixabay/CC0 Public DomainAn international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, has found tha

Updated on:January 29,2024 13

Findings could identify aggressive breast cancers that will respond to immunotherapy

by UNC Lineberger Comprehensive Cancer CenterUNC Lineberger’s Charles M. Perou, PhD. Credit: UNCUniversity of North Carolina Lineberger Comprehensive Cancer Center researchers have discovered a p

Updated on: March 01,2024 17

Findings could identify aggressive breast cancers that will respond to immunotherapy

by UNC Lineberger Comprehensive Cancer CenterUNC Lineberger’s Charles M. Perou, PhD. Credit: UNCUniversity of North Carolina Lineberger Comprehensive Cancer Center researchers have discovered a p

Updated on:March 01,2024 17

Research could lead to more precise diagnosis and treatment of ovarian cancer

by Michael Brown,University of Alberta Faculty of Medicine & DentistryLynne Postovit co-led a new study identifying eight biomarkers that enable pathologists to differentiate between two typ

Updated on: June 28,2024 8

Research could lead to more precise diagnosis and treatment of ovarian cancer

by Michael Brown,University of Alberta Faculty of Medicine & DentistryLynne Postovit co-led a new study identifying eight biomarkers that enable pathologists to differentiate between two typ

Updated on:June 28,2024 8

A promising discovery in the fight against incurable cancers

by Katherine Moss,University of KentT cells induce galectin-9 secretion in human cancer cells derived from solid malignant tumors and keratinocytes. (A) Human cancer cells derived from solid mal

Updated on: February 01,2024 19

A promising discovery in the fight against incurable cancers

by Katherine Moss,University of KentT cells induce galectin-9 secretion in human cancer cells derived from solid malignant tumors and keratinocytes. (A) Human cancer cells derived from solid mal

Updated on:February 01,2024 19

Biosensor detects brain tumors with less than a drop of blood

byAmerican Chemical SocietyGraphical abstract. Credit:ACS Nano(2022). DOI: 10.1021/acsnano.2c04187Despite significant advances, mortality from brain tumors remains high with five-yea

Updated on: January 04,2024 10

Biosensor detects brain tumors with less than a drop of blood

byAmerican Chemical SocietyGraphical abstract. Credit:ACS Nano(2022). DOI: 10.1021/acsnano.2c04187Despite significant advances, mortality from brain tumors remains high with five-yea

Updated on:January 04,2024 10